Amundi Asset Management US’s Immunomedics Inc IMMU Stock Holding History

Amundi Asset Management US’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-396,388	Closed	-$33.7M	–	1646
2020 Q3	$33.7M	Sell	396,388 -157,877	-28%	-$7.98M	0.04%	421
2020 Q2	$19.6M	Buy	554,265 +548,365	+9,294%	+$16M	0.02%	519
2020 Q1	$80K	Hold	5,900	–	–	﹤0.01%	1448
2019 Q4	$125K	Hold	5,900	–	–	﹤0.01%	1540
2019 Q3	$78K	Hold	5,900	–	–	﹤0.01%	1564
2019 Q2	$82K	Hold	5,900	–	–	﹤0.01%	1586
2019 Q1	$113K	Hold	5,900	–	–	﹤0.01%	1540
2018 Q4	$84	Buy	+5,900	New	+$117K	﹤0.01%	1529

Amundi Asset Management US's IMMU Position: Q4 2020 in Review

Amundi Asset Management US sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 396,388 shares — an estimated $33.7M sold.

Amundi Asset Management US first reported a position in IMMU in Q4 2018 and held it in 8 quarters. The position peaked at $33.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Amundi Asset Management US reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Amundi Asset Management US sold 396,388 Immunomedics Inc shares in Q4 2020, an estimated $33.7M.
Amundi Asset Management US first reported a position in Immunomedics Inc in Q4 2018 and held it in 8 quarters.
Amundi Asset Management US's Immunomedics Inc position peaked at $33.7M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Amundi Asset Management US's 13F filing for Q4 2020, filed 16 Feb 2021.